A Study of BMS-986224 in Healthy Subjects and Heart Failure Patients With Reduced Ejection Fraction
NCT03281122
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
199
Enrollment
INDUSTRY
Sponsor class
Stopped
Business objectives have changed
Conditions
Heart Failure
Interventions
DRUG:
Placebo
DRUG:
BMS-986224
Sponsor
Bristol-Myers Squibb